Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

Low capital requirements and high ROC allow Huron Consulting to reinvest cash flow effectively. See why we upgraded HURN ...

Humanity has always searched for answers to its greatest dilemmas—questions that science, medicine, and psychology often ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

In today’s healthcare landscape, “survival” isn’t just a dramatic turn of phrase — for many hospital and health system CFOs, it’s an honest reflection of the stakes. Mounting reimbursement uncertainty ...

QuidelOrtho Corporation (the "Company") or ("QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine ...

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

Seven cross-party New Zealand politicians have just paid a “private” visit to Taiwan. They were received publicly by the ...

ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform purpose-built for the life sciences industry, and ScienceMedia, the pioneer in scientifically validated clinical training, today ...

Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren ...

Researchers affiliated with the UK Health Security Agency (UKHSA) found more than 9,000 people in England were infected with ...